Weekly profile.

WEEKLY PROFILE

DAVITA INC.

Symbol: DVA Exchange: NYSE Close: $32.92 1-WK % Chg: 0.1%

Business Overview

DaVita Inc. is a provider of dialysis services in the United States for
patients suffering from chronic kidney failure, also known as end-stage
renal disease (ESRD). As of December 31, 2003, the company operated or
provided administrative services to approximately 570 outpatient
dialysis centers located in 34 states and the District of Columbia,
serving approximately 48,500 patients. The company also provided acute
inpatient dialysis services in approximately 300 hospitals. All other
activities, which accounted for less than 4% of consolidated revenues
in 2003, related to DaVita's business of providing ESRD laboratory
services, administration of third-party dialysis centers, disease
management services and ESRD clinical research programs.

Income Statement                    LTM *         2003

Revenue (millions)                $2,236.0      $2,016.4
Operating Income (millions)          438.5         385.9
Net Income (millions)                228.5         175.8
EPS                                  $2.21         $1.66

Income Statement                  Summary

Revenue (millions)                Headquarters: El Segundo
Operating Income (millions)       Market Cap: $3.21 billion
Net Income (millions)             Dividend Yield: None
EPS                               P/E Ratio: 15.5

* Latest 12 months ended September 2004